NEW STEP BY STEP MAP FOR ACTIVE PHARMACEUTICAL INGREDIENTS

“The current predicament has exposed some structural weaknesses within the EU’s medicines source chain along with a superior dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides reported. She proposed that provide chain challenges be addressed in an EU pharmaceutical system predicted being launched